{"name":"Anergis","slug":"anergis","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"AllerT full dose","genericName":"AllerT full dose","slug":"allert-full-dose","indication":"Other","status":"phase_2"},{"name":"AllerT2","genericName":"AllerT2","slug":"allert2","indication":"Other","status":"phase_1"},{"name":"AllerT5","genericName":"AllerT5","slug":"allert5","indication":"Other","status":"phase_1"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"AllerT","genericName":"AllerT","slug":"allert","indication":"Allergic rhinitis and asthma (grass pollen allergy)","status":"marketed"},{"name":"AllerT low dose","genericName":"AllerT low dose","slug":"allert-low-dose","indication":"Allergic rhinitis and/or allergic asthma (in development)","status":"phase_2"}]}],"pipeline":[{"name":"AllerT","genericName":"AllerT","slug":"allert","phase":"marketed","mechanism":"AllerT is an allergen immunotherapy that modulates immune tolerance to specific allergens through a peptide-based approach.","indications":["Allergic rhinitis and asthma (grass pollen allergy)"],"catalyst":""},{"name":"AllerT full dose","genericName":"AllerT full dose","slug":"allert-full-dose","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AllerT low dose","genericName":"AllerT low dose","slug":"allert-low-dose","phase":"phase_2","mechanism":"AllerT is an allergen immunotherapy designed to induce immune tolerance to allergens through low-dose, modified allergen exposure.","indications":["Allergic rhinitis and/or allergic asthma (in development)"],"catalyst":""},{"name":"AllerT2","genericName":"AllerT2","slug":"allert2","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AllerT5","genericName":"AllerT5","slug":"allert5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":5,"phaseCounts":{"marketed":1,"phase_2":2,"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}